UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings
AUM
$636M
This Quarter Return
-26.85%
1 Year Return
+18.3%
3 Year Return
+33.03%
5 Year Return
+40.39%
10 Year Return
–
AUM
$203M
AUM Growth
+$203M
(-27%)
Cap. Flow
+$844K
Cap. Flow
% of AUM
0.42%
Top 10 Holdings %
Top 10 Hldgs %
98.31%
Holding
25
New
7
Increased
4
Reduced
2
Closed
3
Top Buys
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$745K |
| 2 |
Vanguard Energy ETF
VDE
|
$693K |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$551K |
| 4 |
Vanguard Mid-Cap Value ETF
VOE
|
$471K |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
$437K |
Top Sells
| 1 |
SPDR Gold Trust
GLD
|
$1.73M |
| 2 |
MBLY
Mobileye N.V.
MBLY
|
$207K |
| 3 |
Vanguard S&P 500 ETF
VOO
|
$200K |
| 4 |
Invesco
IVZ
|
$187K |
| 5 |
Vanguard Real Estate ETF
VNQ
|
$20.6K |
Sector Composition
| 1 | Healthcare | 88.99% |
| 2 | Energy | 2.74% |
| 3 | Technology | 0.79% |
| 4 | Materials | 0.42% |
| 5 | Utilities | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alaunos Therapeutics
TCRT
$4.21M
| $109M | 53.44% | 12,062,803 | – | – |
|
2
Precigen
PGEN
$1.34B
| $66.8M | 32.84% | 2,100,085 | – | – |
|
|
WPZ
3
DELISTED
Williams Partners L.P.
WPZ
| $5.51M | 2.71% | 172,732 | – | – |
|
|
BPTH
4
DELISTED
Bio-Path Holdings Inc
BPTH
| $4.37M | 2.15% | 3,830,882 | – | – |
|
|
5
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $2.76M | 1.36% | 77,475 +12,271 | +19% | +$437K |
|
|
6
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| $2.75M | 1.35% | 83,061 +22,520 | +37% | +$745K |
|
|
7
Vanguard S&P 500 ETF
VOO
$726B
| $2.69M | 1.32% | 15,283 -1,138 | -7% | -$200K |
|
|
8
Vanguard Mid-Cap Value ETF
VOE
$18.8B
| $2.65M | 1.31% | 31,889 +5,655 | +22% | +$471K |
|
|
9
Vanguard Energy ETF
VDE
$7.42B
| $2.14M | 1.05% | 25,214 +8,175 | +48% | +$693K |
|
10
Texas Instruments
TXN
$184B
| $1.59M | 0.78% | 32,000 | – | – |
|
|
11
Vanguard Real Estate ETF
VNQ
$34.6B
| $1.37M | 0.67% | 18,158 -273 | -1% | -$20.6K |
|
|
GMO
12
DELISTED
General Moly, Inc.
GMO
| $844K | 0.42% | 2,922,831 | – | – |
|
|
SAGE
13
DELISTED
Sage Therapeutics
SAGE
| $551K | 0.27% | +13,018 | New | +$551K |
|
14
Lexicon Pharmaceuticals
LXRX
$400M
| $384K | 0.19% | 35,714 | – | – |
|
15
Arrowhead Research
ARWR
$3.05B
| $206K | 0.1% | +35,817 | New | +$206K |
|
16
Kinder Morgan
KMI
$60B
| $53K | 0.03% | +1,912 | New | +$53K |
|
17
IBM
IBM
$227B
| $17K | 0.01% | +120 | New | +$17K |
|
18
Exxon Mobil
XOM
$487B
| $8K | ﹤0.01% | +110 | New | +$8K |
|
19
Portland General Electric
POR
$4.69B
| $4K | ﹤0.01% | 118 | – | – |
|
20
Equifax
EFX
$30.3B
| $3K | ﹤0.01% | 29 | – | – |
|
21
Pfizer
PFE
$141B
| $3K | ﹤0.01% | +100 | New | +$3K |
|
22
Raymond James Financial
RJF
$33.8B
| $1K | ﹤0.01% | +21 | New | +$1K |
|
|
23
SPDR Gold Trust
GLD
$107B
| – | – | -15,361 | Closed | -$1.73M |
|
|
24
Invesco
IVZ
$9.76B
| – | – | -5,000 | Closed | -$187K |
|
|
MBLY
25
DELISTED
Mobileye N.V.
MBLY
| – | – | -3,900 | Closed | -$207K |
|